Literature DB >> 28600885

Immunolocalization of TAR DNA-binding protein of 43 kDa (TDP-43) in mouse seminiferous epithelium.

Hari Prasad Osuru1, Patcharin Pramoonjago1, Mayuresh M Abhyankar1, Eric Swanson1, LaToya Ann Roker1, Helen Cathro1, Prabhakara P Reddi2.   

Abstract

TAR DNA-binding protein of 43 kDa (TDP-43) is an evolutionarily conserved, ubiquitously expressed, multi-functional DNA/RNA-binding protein with roles in gene transcription, mRNA splicing, stability, transport, micro RNA biogenesis, and suppression of transposons. Aberrant expression of TDP-43 in testis and sperm was recently shown to be associated with male infertility, which highlights the need to understand better the expression of TDP-43 in the testis. We previously cloned TDP-43 from a mouse testis cDNA library, and showed that it functions as a transcriptional repressor and regulates the precise spatiotemporal expression of the Acrv1 gene, which encodes the acrosomal protein SP-10, during spermatogenesis. Here, we performed immunoblotting and immunohistochemistry of the mouse testis using four separate antibodies recognizing the amino and carboxyl termini of TDP-43. TDP-43 is present in the nuclei of germ cells as well as Sertoli cells. TDP-43 expression begins in type B/intermediate spermatogonia, peaks in preleptotene spermatocytes, and becomes undetectable in leptotene and zygotene spermatocytes. Pachytene spermatocytes and early round spermatids again express TDP-43, but its abundance diminishes later in spermatids (at steps 5-8). Interestingly, two of the four antibodies showed TDP-43 expression in spermatids at steps 9-10, which coincides with the initial phase of the histone-to-protamine transition. Immunoreactivity patterns observed in the study suggest that TDP-43 assumes different conformational states at different stages of spermatogenesis. TDP-43 pathology has been extensively studied in the context of neurodegenerative diseases; its role in spermatogenesis warrants further detailed investigation of the involvement of TDP-43 in male infertility.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  fertility; regulation of gene expression; spermatogenesis; testis

Mesh:

Substances:

Year:  2017        PMID: 28600885      PMCID: PMC5577912          DOI: 10.1002/mrd.22851

Source DB:  PubMed          Journal:  Mol Reprod Dev        ISSN: 1040-452X            Impact factor:   2.609


  23 in total

1.  The acrosomal protein SP-10 (Acrv1) is an ideal marker for staging of the cycle of seminiferous epithelium in the mouse.

Authors:  Hari Prasad Osuru; Jennifer E Monroe; Apoorv P Chebolu; Joycelyn Akamune; Patcharin Pramoonjago; Sandeep A Ranpura; Prabhakara P Reddi
Journal:  Mol Reprod Dev       Date:  2014-08-26       Impact factor: 2.609

2.  Pathological heterogeneity of frontotemporal lobar degeneration with ubiquitin-positive inclusions delineated by ubiquitin immunohistochemistry and novel monoclonal antibodies.

Authors:  Deepak M Sampathu; Manuela Neumann; Linda K Kwong; Thomas T Chou; Matthew Micsenyi; Adam Truax; Jennifer Bruce; Murray Grossman; John Q Trojanowski; Virginia M-Y Lee
Journal:  Am J Pathol       Date:  2006-10       Impact factor: 4.307

3.  Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.

Authors:  Manuela Neumann; Deepak M Sampathu; Linda K Kwong; Adam C Truax; Matthew C Micsenyi; Thomas T Chou; Jennifer Bruce; Theresa Schuck; Murray Grossman; Christopher M Clark; Leo F McCluskey; Bruce L Miller; Eliezer Masliah; Ian R Mackenzie; Howard Feldman; Wolfgang Feiden; Hans A Kretzschmar; John Q Trojanowski; Virginia M-Y Lee
Journal:  Science       Date:  2006-10-06       Impact factor: 47.728

4.  Aggregate formation prevents dTDP-43 neurotoxicity in the Drosophila melanogaster eye.

Authors:  Lucia Cragnaz; Raffaela Klima; Natasa Skoko; Mauricio Budini; Fabian Feiguin; Francisco E Baralle
Journal:  Neurobiol Dis       Date:  2014-07-31       Impact factor: 5.996

5.  Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.

Authors:  Masato Hasegawa; Tetsuaki Arai; Takashi Nonaka; Fuyuki Kametani; Mari Yoshida; Yoshio Hashizume; Thomas G Beach; Emanuele Buratti; Francisco Baralle; Mitsuya Morita; Imaharu Nakano; Tatsuro Oda; Kuniaki Tsuchiya; Haruhiko Akiyama
Journal:  Ann Neurol       Date:  2008-07       Impact factor: 10.422

Review 6.  The molecular links between TDP-43 dysfunction and neurodegeneration.

Authors:  Emanuele Buratti; Francisco E Baralle
Journal:  Adv Genet       Date:  2009       Impact factor: 1.944

7.  Identification of cell-specific targets of sumoylation during mouse spermatogenesis.

Authors:  Yuxuan Xiao; Daniel Pollack; Miriam Andrusier; Avi Levy; Myrasol Callaway; Edward Nieves; Prabhakara Reddi; Margarita Vigodner
Journal:  Reproduction       Date:  2016-02       Impact factor: 3.906

8.  TDP-43 dimerizes in human cells in culture.

Authors:  Yuki Shiina; Kunimasa Arima; Hiroko Tabunoki; Jun-ichi Satoh
Journal:  Cell Mol Neurobiol       Date:  2009-12-31       Impact factor: 5.046

9.  Proteolytic processing of TAR DNA binding protein-43 by caspases produces C-terminal fragments with disease defining properties independent of progranulin.

Authors:  Dorothee Dormann; Anja Capell; Aaron M Carlson; Sunita S Shankaran; Ramona Rodde; Manuela Neumann; Elisabeth Kremmer; Takashi Matsuwaki; Keitaro Yamanouchi; Masugi Nishihara; Christian Haass
Journal:  J Neurochem       Date:  2009-06-09       Impact factor: 5.372

10.  Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping.

Authors:  E Buratti; T Dörk; E Zuccato; F Pagani; M Romano; F E Baralle
Journal:  EMBO J       Date:  2001-04-02       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.